GlassScriptPhysician profile
Andrew Scott Barner
NPI 1104339670
$3,743.62
in general payments reported to CMS, 2019-2025
16 companies · $2,168 in 2025
The $2,168 reported for 2025 was more than what 95% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $757 · 2024: $819 · 2025: $2,168.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,744.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,743.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $943.69 | 2023-2025 | |
| Ardelyx, INC. | $473.78 | 2025 | Ibsrela |
| E.R. Squibb & Sons, L.L.C. | $468.06 | 2023-2024 | Zeposia |
| Madrigal Pharmaceuticals | $418.02 | 2025 | Rezdiffra |
| Janssen Biotech, INC. | $324.88 | 2024-2025 | Tremfya |
| Lilly USA, LLC | $297.31 | 2024-2025 | Omvoh |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $242.09 | 2025 | Xifaxan |
| Genzyme Corporation | $171.69 | 2024-2025 | |
| Gilead Sciences, INC. | $150.00 | 2025 | Livdelzi |
| Boston Scientific Corporation | $96.09 | 2023 | Exalt Model D |
| Celgene Corporation | $33.57 | 2024 | Zeposia |
| Redhill Biopharma INC. | $28.85 | 2024 | Talicia |
| Nestle Healthcare Nutrition INC. | $27.48 | 2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $27.07 | 2023 | Entyvio |
| Pfizer INC. | $22.90 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $18.14 | 2025 | Proximate |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Barner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.